Leighanne Oh is a Vice President at Ascenta Capital, specializing in biotech and life sciences investments. Her career spans private and public investing at Novo Holdings and Sofinnova Investments, healthcare investment banking at Jefferies, and biomedical engineering at GE Healthcare. She earned her M. S. in Biomedical Engineering from Duke University.
Read the full overview →They are more likely than others to negotiate on pricing and terms. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They prefer to do thorough analysis of any situation.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.